Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Shroyer

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Human Pathology|August 28, 2002
Immunohistochemical markers of cell immortalityKenneth R Shroyer
Diagnostic Cytopathology|July 13, 2017
Strategies for building a successful ultrasound guided FNA practice in department of pathology-Experience at a university hospitalMaoxin Wu, Kenneth R Shroyer
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2014
Comments on "HPV and lung cancer risk: a meta-analysis" [Zhai et al., J. Clin. Virol. (in press)]Elizabeth A Vanner, Kenneth R Shroyer
Journal of Oncology|December 2, 2011
Biomarkers of cervical dysplasia and carcinomaSonya J Hwang, Kenneth R Shroyer
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 24, 2011
Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesionsPanduka Samarawardana, Meenakshi Singh, Kenneth R Shroyer
MLO: Medical Laboratory Observer|February 19, 2016
Unmet clinical needs in cervical cancer screeningJianyu Rao, Luisa Escobar-Hoyos, Kenneth R Shroyer
Human Pathology|January 22, 2008
Human papillomavirus: molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinomaJohn Thomison, Laurie K Thomas, Kenneth R Shroyer
Cancer|January 16, 2007
Human papillomavirus testing and molecular markers of cervical dysplasia and carcinomaDonna Dehn, Kathleen C Torkko, Kenneth R Shroyer
Cancer|August 29, 2006
Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytologyKenneth R Shroyer, Petra Homer, David Heinz, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 29, 2012
Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovaryPenelope Georgakopoulos, Saira Mehmood, Ali Akalin, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Human Pathology|August 28, 2002
Immunohistochemical markers of cell immortalityKenneth R Shroyer
Diagnostic Cytopathology|July 13, 2017
Strategies for building a successful ultrasound guided FNA practice in department of pathology-Experience at a university hospitalMaoxin Wu, Kenneth R Shroyer
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2014
Comments on "HPV and lung cancer risk: a meta-analysis" [Zhai et al., J. Clin. Virol. (in press)]Elizabeth A Vanner, Kenneth R Shroyer
Journal of Oncology|December 2, 2011
Biomarkers of cervical dysplasia and carcinomaSonya J Hwang, Kenneth R Shroyer
Applied Immunohistochemistry & Molecular Morphology : AIMM|May 24, 2011
Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesionsPanduka Samarawardana, Meenakshi Singh, Kenneth R Shroyer
MLO: Medical Laboratory Observer|February 19, 2016
Unmet clinical needs in cervical cancer screeningJianyu Rao, Luisa Escobar-Hoyos, Kenneth R Shroyer
Human Pathology|January 22, 2008
Human papillomavirus: molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinomaJohn Thomison, Laurie K Thomas, Kenneth R Shroyer
Cancer|January 16, 2007
Human papillomavirus testing and molecular markers of cervical dysplasia and carcinomaDonna Dehn, Kathleen C Torkko, Kenneth R Shroyer
Cancer|August 29, 2006
Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytologyKenneth R Shroyer, Petra Homer, David Heinz, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 29, 2012
Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovaryPenelope Georgakopoulos, Saira Mehmood, Ali Akalin, et al.
Pageof 14